Navigation Links
Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference
Date:5/8/2008

PALO ALTO, Calif., May 8 /PRNewswire/ -- Anacor Pharmaceuticals announced today that it will present six posters on topical anti-inflammatory candidates, AN2728 and AN2898, at the upcoming International Investigative Dermatology 2008 Conference, taking place May 14-17, 2008 in Kyoto, Japan. The IID Conference is the Fifth Joint Meeting of the European Society for Dermatological Research (ESDR), the Japanese Society for Investigative Dermatology (JSID) and the Society for Investigative Dermatology (SID).

Poster Presentations:

Poster Session 1: Friday May 16, 5:30-7 p.m.

Poster title (#89): In vitro activity and mechanism of action of AN2728,

a novel oxaborole in development for treatment of psoriasis

Poster title (#367): AN2728, a novel oxaborole in development for

treatment of psoriasis, demonstrates significant activity in a micro

plaque study

Poster Session 2: Saturday May 17, 1:15-2:45 p.m.

Poster title (#84): Preclinical toxicology of AN2728, a novel oxaborole

in development for the topical treatment of psoriasis

Poster title (#86): AN2898, a novel oxaborale compound with

anti-inflammatory activity: mechanism of action and in vitro cytokine

inhibition

Poster title (#88): Structure-activity studies of AN2728 and AN2898,

novel oxaborole compounds with anti-inflammatory activities

Poster title (#90): AN2898, a novel oxaborale compound with

anti-inflammatory activity: results of in vivo efficacy and preclinical

safety studies

About Anacor Pharmaceuticals

Anacor is a biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform. Anacor has focused initially on developing topical applications of its compounds to treat fungal, bacterial and inflammatory diseases. Anacor's most advanced product candidate is AN2690, a novel topical antifungal in development for th
'/>"/>

SOURCE Anacor Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Anacor Files Registration Statement for Initial Public Offering
2. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
3. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
4. Avicena Group to Present at Noble Financial Conference
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CEL-SCI to Present at the Noble Financial Conference
9. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Strategic Diagnostics Updates Roth Conference Presentation Time

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... new generation of ultrasmall transistors and more...led semiconducting nanowires are closer to reality...ue University and the University of California at ...to create nanowires with layers of different mater... which is a critical requirement for making effici...
(Date:11/25/2009)... ,, BOCA RATON, Fla., Nov. 25 ... Not so for BodyLogicMD. The nation,s largest and...ializing exclusively in medically supervised bioi...sicians in its network since November 2008 - fr...d more physician-owned centers, including one in P...
(Date:11/25/2009)...5 Ardea Biosciences, Inc...uart, Pharm.D., president and chief executive offi... Health Care Conference. , ,Presentation details ...Care Conference,Date: Tuesday, December 1, 20...e New York Palace Hotel, New York, NY,Webcast: ...
(Date:11/24/2009)...New York investment bank KTA Capital,s client Neur...6.7 mil convertible note private placement with a ... was arranged by KTA Capital as Neuren,s exclusive... New York (PRWEB) November 23, 2009 -- The i...LC ("KTA Capital") has announced that it...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...Call/ - Neptune Technologies &,Bioressources Inc. ...ced,operational and financial results for the fisc...February 29, 2008 and provided an update on recent...w by 22% in the three-month period ended February ...ebruary 28, 2007 and 29% in,the nine months ended ...
...-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS...egic,restructuring plan to significantly reduce it...ities that the Board and management believe are mo...This plan re-focuses,Vasogen,s resources on the de...any seeks alternatives to fund further development...
...14 ,ExlService Holdings, Inc. (Nasdaq: EXLS ), a ...nnounced that Rembert de Villa has joined as Head ...ervices offerings focus on,helping clients improve...analytics, streamlining and improving business pro...s. Under the banner of Transformation Services,Rem...
Other Biology Technology:Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones 2Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones 3Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones 4Vasogen Announces Implementation of Strategic Restructuring Plan 2Vasogen Announces Implementation of Strategic Restructuring Plan 3Vasogen Announces Implementation of Strategic Restructuring Plan 4Vasogen Announces Implementation of Strategic Restructuring Plan 5EXL Announces Appointment of Rembert de Villa as Head of Transformation Services 2EXL Announces Appointment of Rembert de Villa as Head of Transformation Services 3EXL Announces Appointment of Rembert de Villa as Head of Transformation Services 4
(Date:11/24/2009)...9) -- The Wildlife Conservation Society (WCS) anno...ning population of Siberian tigers has likely decl...ing and habitat loss. , WCS says the... needs to be done to protect remaining populations...report was released by the Siberian Tiger Monitori...
(Date:11/24/2009)...search on bacterial communities throughout six lar...poral patterns, suggesting that scientists could u...mate change in the polar regions. The study, publi... Academy of Sciences Early Edition, shows that ba...hronously over time, correlating with seasonal shi...
(Date:11/23/2009)... strain of the deadly superbug MRSAan infection-ca...sposes a far greater health threat than previously...ding to a study in the December issue of Emerging...ly picked up in fitness centers, schools, and othe...en of MRSA within hospitals, the report found. , ...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New study finds MRSA on the rise in hospital outpatients 2Drinking milk in the morning may help stave off lunchtime hunger 8943 1Drinking milk in the morning may help stave off lunchtime hunger 8943 2Snoring Isn 26apos 3Bt Sexy LLC Launches Survey to Determine Extent of Drowsy Drivers on Land Sea and In The Air 49556 1Snoring Isn 26apos 3Bt Sexy LLC Launches Survey to Determine Extent of Drowsy Drivers on Land Sea and In The Air 49556 2WuXi PharmaTech Appoints Wei Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility Eric Gu as Vice Presid 12715 1WuXi PharmaTech Appoints Wei Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility Eric Gu as Vice Presid 12715 2
...cally reduced the amount a heavy drinker will cons....,Heavy-drinking smokers in a laboratory setting w...g varenicline compared to those taking a placebo, ...al Biological Psychiatry . , The group taking va...me Chantix, reported feeling fewer cravings for al...
...for generations their apparent ability to store f...rtionally fewer calories. , While it has long be...ble, a University of New South Wales (UNSW) resear...een one hormone oestrogen and its impact on fat ...e 6 to 11 percent more body fat than men. Studies ...
...he way that proteins fold is vital to ensuring the...rsity of Leeds have discovered this is a ,hit and ...rongly many times before they form the correct str...proteins carry out numerous functions and play a c...cells. Sheena Radford, Professor of Structural Mol...
Other Biology News:1 drug may help people both lay down the drink and put out the cigarette 2Why do women store fat differently from men? 2Unfolding 'nature's origami' 2
Acridinium NHS ester from Cayman Chemical
...olor real-time PCR detection system holds 48 x 0.2... LEDs independently excites fluorescence (470-500 ...des detects emitted light (523-543 nm and 540-700 ...e Peltier heat pumps provide superb thermal perfor...
... making flow cytometry accessible to anyone in the... latest addition to Guavas on-demand microcapillar... easy to use, surprisingly affordable, very compac...or detection. The Guava EasyCyte Mini has all of t...
...t designed to hold up to 6 strain chambers with pr...asy to use design ensures that cells grow over lon...r compression. This unit allows you to control the...unique strain settings. The instrument fits in a s...
Biology Products: